Atlas Trials

Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine

Clinical trial NCT07232745 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07232745
Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2025-10-12
Primary completion
2025-11-10
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.